{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:45:02Z","timestamp":1794203102356,"version":"4.8.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pathogen infections have been associated with autoimmunity, which in turn has been implicated in the pathogenesis of vitiligo. However, the association between pathogen infections and vitiligo remains elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>This study aimed to assess the proportion of individuals who tested positive for specific IgG antibodies against selected pathogens in patients with vitiligo and control subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      Plasma from 51 patients with vitiligo and 51 age- and gender-matched controls were tested for anti-\n                      <jats:italic toggle=\"yes\">Toxoplasma gondii (T. gondii)<\/jats:italic>\n                      IgG, anti-herpes simplex types 1 and 2 (HSV-1\/2) IgG, anti-cytomegalovirus (CMV) IgG and anti-hepatitis C virus IgG.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among all participants (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 102), 63%, 84% and 87% tested positive for anti-T. gondii, anti-HSV-1\/2 and anti-CMV IgG antibodies, respectively. Anti-hepatitis C virus IgG was negative in all samples tested. Positive anti-\n                      <jats:italic toggle=\"yes\">T. gondii<\/jats:italic>\n                      IgG was detected in plasma samples of 39 (78%) patients with vitiligo and 25 (49%) controls (odds ratio [OR] 3.68, 95% confidence interval [CI] 1.55\u20138.76,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0036). Anti\n                      <jats:italic toggle=\"yes\">-<\/jats:italic>\n                      HSV-1\/2 IgG was detected in samples of 47 (92%) patients with vitiligo and 38 (76%) controls (OR 3.71, 95% CI 1.11\u201312.44,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.031). Differences in frequencies of positive results for anti-\n                      <jats:italic toggle=\"yes\">T. gondii<\/jats:italic>\n                      IgG and anti-HSV-1\/2 IgG were only significant in samples from female patients with vitiligo when compared with controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.036 and 0.024, respectively). Anti-CMV IgG was detected in samples from 46 patients with vitiligo (90%) and 41 (84%) controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.384).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">T. gondii<\/jats:italic>\n                      IgG and HSV-1\/2 IgG were significantly more frequent in patients with vitiligo, especially in women, when compared with age- and gender-matched controls. Since\n                      <jats:italic toggle=\"yes\">T. gondii<\/jats:italic>\n                      and HSV-1\/2 infections can trigger autoimmune events, past exposure to these pathogens may be a risk factor for the development of vitiligo.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_950_22","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T17:14:45Z","timestamp":1724951685000},"page":"588","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of Serum Immunoglobulin G (IgG) Levels against Toxoplasma Gondii, Herpes Simplex Virus Types 1 and 2, Cytomegalovirus and Hepatitis C Virus in Vitiligo"],"prefix":"10.4103","volume":"68","author":[{"given":"Rachel de Paula","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenia A. P.","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia A.","family":"Guillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20240829","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2010.01139.x","article-title":"Vitiligo: A review of the published work","volume":"38","author":"Yaghoobi","year":"2011","journal-title":"J Dermatol"},{"key":"R2-27-20240829","doi-asserted-by":"crossref","first-page":"e0163806","DOI":"10.1371\/journal.pone.0163806","article-title":"The prevalence of vitiligo: A meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"R3-27-20240829","first-page":"44","article-title":"New insights into immune mechanisms of vitiligo","volume":"151","author":"Boniface","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"key":"R4-27-20240829","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","article-title":"Autoimmunity as an aetiological factor in vitiligo","volume":"21","author":"Rezaei","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R5-27-20240829","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s00296-012-2451-z","article-title":"Infection and autoimmune disease","volume":"32","author":"Sener","year":"2012","journal-title":"Rheumatol Int"},{"key":"R6-27-20240829","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(96)90490-9","article-title":"Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo","volume":"35","author":"Grimes","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"R7-27-20240829","first-page":"401","article-title":"Herpes simplex labialis is a risk factor for vitiligo (post-herpes simplex labialis vitiligo)","volume":"12","author":"Elethawi","year":"2013","journal-title":"Iraqi Postgrad Med J"},{"key":"R8-27-20240829","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1346-8138.2000.tb02196.x","article-title":"Vitiligo vulgaris associated with hepatitis C virus","volume":"27","author":"Yamamoto","year":"2000","journal-title":"J Dermatol"},{"key":"R10-27-20240829","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/01.mcg.0000139052.74801.98","article-title":"Is there any relationship between hepatitis C virus and vitiligo?","volume":"38","author":"Akbayir","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"R12-27-20240829","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1413-8670(10)70118-5","article-title":"Seropositivity rates for toxoplasmosis, rubella, syphilis, cytomegalovirus, hepatitis and HIV among pregnant women receiving care at a public health service, Sao Paulo state, Brazil","volume":"14","author":"dos","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"R13-27-20240829","first-page":"535","article-title":"[Spatial distribution of anti-toxoplasma antibodies in pregnant women from Aracaju, Sergipe, Brazil]","volume":"36","author":"de Melo Inagaki","year":"2014","journal-title":"Rev Bras Ginecol Obstet"},{"key":"R14-27-20240829","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1590\/S0100-72032011000200007","article-title":"[Prenatal screening for toxoplasmosis and factors associated with seropositivity of pregnant women in Goiania, Goias]","volume":"33","author":"Sartori","year":"2011","journal-title":"Rev Bras Ginecol Obstet"},{"key":"R15-27-20240829","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1590\/S0034-89102010000400017","article-title":"Seroprevalence of herpes simplex 1-2 antibodies in Brazil","volume":"44","author":"Clemens","year":"2010","journal-title":"Rev Saude Publica"},{"key":"R16-27-20240829","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0037-86822010000400004","article-title":"Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil","volume":"43","author":"Souza","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"key":"R17-27-20240829","first-page":"1","article-title":"Seroprevalence of cytomegalovirus infection among healthy blood donors in Bahia State, Brazil","volume":"32","author":"Matos","year":"2010","journal-title":"Rev Bras Hematol Hemater"},{"key":"R18-27-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2376-0427.1000105","article-title":"No evidence of HSV presence in the serum of vitiligo patients","volume":"1","author":"Liu","year":"2014","journal-title":"J Pigment Disord"},{"key":"R19-27-20240829","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4172\/2376-0427.1000246","article-title":"HSV-1 enters melanocytes and induces their apoptosis","volume":"3","author":"Lan","year":"2016","journal-title":"J Pigment Disord"},{"key":"R20-27-20240829","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1468-3083.2006.01822.x","article-title":"Is there any relation between vitiligo and cytomegalovirus?","volume":"21","author":"Toker","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R21-27-20240829","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1034\/j.1600-0749.2002.1l084.x","article-title":"Vitiligo: cytomegalovirus associated?","volume":"15","author":"Akar","year":"2002","journal-title":"Pigment Cell Res"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_950_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:09:03Z","timestamp":1787771343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_950_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_950_22","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}